Zohar Koren
Amministratore Delegato presso SciCann Therapeutics, Inc.
Profilo
Zohar Koren was the founder of Cannabics, Inc. (2012), CNBX Pharmaceuticals, Inc. (2014), and Xinteza API Ltd.
(2019) where he held the titles of Chief Executive Officer & Director (2014-2015) and Chief Technology Officer (2019-present).
Dr. Koren is also the founder of SciCann Therapeutics, Inc. He previously worked as a Director at Alterola Biotech, Inc. Dr. Koren received his undergraduate degree from The Hebrew University of Jerusalem and his graduate and doctorate degrees from the University of Haifa.
Posizioni attive di Zohar Koren
Società | Posizione | Inizio |
---|---|---|
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SciCann Therapeutics, Inc. develops pharmaceuticals. The Canadian company was founded by Zohar Koren. Zohar Koren has been the CEO since incorporation. | Amministratore Delegato | - |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Xinteza Ltd. is developing proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients for pharmaceutical and food industries. The company was founded by Alon Gal on March 17, 2019 and is headquartered in Tel Aviv, Israel. | Fondatore | 17/03/2019 |
Precedenti posizioni note di Zohar Koren
Società | Posizione | Fine |
---|---|---|
CNBX PHARMACEUTICALS INC. | Fondatore | 23/01/2015 |
ALTEROLA BIOTECH, INC. | Direttore/Membro del Consiglio | - |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Cannabics, Inc. provides cannabinoid-based therapy solutions. The firm specializes in molecular biology, cancer research and pharmacology. The company was founded by Itamar Borochov, Eyal Ballan and Zohar Koren on December 7, 2012 and is headquartered in Wilmington, DE. | Fondatore | - |
Formazione di Zohar Koren
The Hebrew University of Jerusalem | Undergraduate Degree |
University of Haifa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CNBX PHARMACEUTICALS INC. | Health Technology |
Aziende private | 4 |
---|---|
Alterola Biotech, Inc. (California)
Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Alterola Biotech, Inc. is a development stage company. It engages in the development of chewing gums for the delivery of nutraceutical and functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant. The company was founded on July 21, 2008 and is headquartered in Walnut, CA. | Process Industries |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Cannabics, Inc. provides cannabinoid-based therapy solutions. The firm specializes in molecular biology, cancer research and pharmacology. The company was founded by Itamar Borochov, Eyal Ballan and Zohar Koren on December 7, 2012 and is headquartered in Wilmington, DE. | Finance |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Xinteza Ltd. is developing proprietary technologies related to the production of cannabinoid-based active pharmaceutical ingredients for pharmaceutical and food industries. The company was founded by Alon Gal on March 17, 2019 and is headquartered in Tel Aviv, Israel. | Health Technology |
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SciCann Therapeutics, Inc. develops pharmaceuticals. The Canadian company was founded by Zohar Koren. Zohar Koren has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Zohar Koren